Halil Bagci

Halil Bagci

Auto-generated profile, based on publicly available information

Halil Bagci

ETH Zurich

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Molecular Cell
Verified
Journal Article
Closed access
JYJi-Young Youn
Ji-Young Youn
WDWade H. Dunham
Wade H. Dunham
SHSeo Jung Hong
Seo Jung Hong
JKJames D.R. Knight
James D.R. Knight
MBMikhail Bashkurov
Mikhail Bashkurov
AGAnne-Claude Gingras
Anne-Claude Gingras

23 December 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
HBHalil Bagci
Halil Bagci
NSNeera Sriskandarajah
Neera Sriskandarajah
ARAmélie Robert
Amélie Robert
JBJonathan Boulais
Jonathan Boulais
IEIslam E. Elkholi
Islam E. Elkholi
JCJean-François Côté
Jean-François Côté

28 August 2018 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SFSteven Findlay
Steven Findlay
JHJohn Heath
John Heath
VLVincent M Luo
Vincent M Luo
AMAbba Malina
Abba Malina
TMThéo Morin
Théo Morin
AOAlexandre Orthwein
Alexandre Orthwein
DNA double‐strand breaks (DSBs) can be repaired by two major pathways: non‐homologous end‐joining (NHEJ) and homologous recombination (HR). DNA repair pathway choice is governed by the opposing activities of 53BP1, in complex with its effectors RIF1 and REV7, and BRCA1. However, it remains unknown how the 53BP1/RIF1/REV7 complex stimulates NHEJ and restricts HR to the S/G2 phases of the cell cycle. Using a mass spectrometry (MS)‐based approach, we identify 11 high‐confidence REV7 interactors and elucidate the role of SHLD2 (previously annotated as FAM35A and RINN2) as an effector of REV7 in the NHEJ pathway. FAM35A depletion impairs NHEJ‐mediated DNA repair and compromises antibody diversification by class switch recombination (CSR) in B cells. FAM35A accumulates at DSBs in a 53BP1‐, RIF1‐, and REV7‐dependent manner and antagonizes HR by limiting DNA end resection. In fact, FAM35A is part of a larger complex composed of REV7 and SHLD1 (previously annotated as C20orf196 and RINN3), which promotes NHEJ and limits HR. Together, these results establish SHLD2 as a novel effector of REV7 in controlling the decision‐making process during DSB repair.

17 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
AAAfnan Abu-Thuraia
Afnan Abu-Thuraia
MGMarie-Anne Goyette
Marie-Anne Goyette
JBJonathan Boulais
Jonathan Boulais
CDCarine Delliaux
Carine Delliaux
CAChloé Apcher
Chloé Apcher
JCJean-François Côté
Jean-François Côté
Aberrant expression of receptor tyrosine kinase AXL is linked to metastasis. AXL can be activated by its ligand GAS6 or by other kinases, but the signaling pathways conferring its metastatic activity are unknown. Here, we define the AXL-regulated phosphoproteome in breast cancer cells. We reveal that AXL stimulates the phosphorylation of a network of focal adhesion (FA) proteins, culminating in faster FA disassembly. Mechanistically, AXL phosphorylates NEDD9, leading to its binding to CRKII which in turn associates with and orchestrates the phosphorylation of the pseudo-kinase PEAK1. We find that PEAK1 is in complex with the tyrosine kinase CSK to mediate the phosphorylation of PAXILLIN. Uncoupling of PEAK1 from AXL signaling decreases metastasis in vivo, but not tumor growth. Our results uncover a contribution of AXL signaling to FA dynamics, reveal a long sought-after mechanism underlying AXL metastatic activity, and identify PEAK1 as a therapeutic target in AXL positive tumors.

28 March 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMStephen P. Methot
Stephen P. Methot
LLLudivine C. Litzler
Ludivine C. Litzler
PSPoorani Ganesh Subramani
Poorani Ganesh Subramani
AEAnil K. Eranki
Anil K. Eranki
HFHeather Fifield
Heather Fifield
JNJavier M. Di Noia
Javier M. Di Noia
Activation-induced deaminase (AID) mutates the immunoglobulin (Ig) genes to initiate somatic hypermutation (SHM) and class switch recombination (CSR) in B cells, thus underpinning antibody responses. AID mutates a few hundred other loci, but most AID-occupied genes are spared. The mechanisms underlying productive deamination versus non-productive AID targeting are unclear. Here we show that three clustered arginine residues define a functional AID domain required for SHM, CSR, and off-target activity in B cells without affecting AID deaminase activity or Escherichia coli mutagenesis. Both wt AID and mutants with single amino acid replacements in this domain broadly associate with Spt5 and chromatin and occupy the promoter of AID target genes. However, mutant AID fails to occupy the corresponding gene bodies and loses association with transcription elongation factors. Thus AID mutagenic activity is determined not by locus occupancy but by a licensing mechanism, which couples AID to transcription elongation.

20 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
PSPeiman Shooshtarizadeh
Peiman Shooshtarizadeh
AHAnne Helness
Anne Helness
CVCharles Vadnais
Charles Vadnais
NBNelleke Brouwer
Nelleke Brouwer
HBHugues Beauchemin
Hugues Beauchemin
TMTarik Möröy
Tarik Möröy
Gfi1b is a transcriptional repressor expressed in hematopoietic stem cells (HSCs) and megakaryocytes (MKs). Gfi1b deficiency leads to expansion of both cell types and abrogates the ability of MKs to respond to integrin. Here we show that Gfi1b forms complexes with β-catenin, its co-factors Pontin52, CHD8, TLE3 and CtBP1 and regulates Wnt/β-catenin-dependent gene expression. In reporter assays, Gfi1b can activate TCF-dependent transcription and Wnt3a treatment enhances this activation. This requires interaction between Gfi1b and LSD1 and suggests that a tripartite β-catenin/Gfi1b/LSD1 complex exists, which regulates Wnt/β-catenin target genes. Consistently, numerous canonical Wnt/β-catenin target genes, co-occupied by Gfi1b, β-catenin and LSD1, have their expression deregulated in Gfi1b-deficient cells. When Gfi1b-deficient cells are treated with Wnt3a, their normal cellularity is restored and Gfi1b-deficient MKs regained their ability to spread on integrin substrates. This indicates that Gfi1b controls both the cellularity and functional integrity of HSCs and MKs by regulating Wnt/β-catenin signaling pathway.